Added to YB: 2024-12-12
Pitch date: 2024-12-12
USAQ [neutral]
QHSLab, Inc.
+249.54%
current return
Author Info
No bio for this author
Company Info
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures.
Market Cap
$11.4M
Pitch Price
$0.18
Price Target
N/A
Dividend
N/A
EV/EBITDA
53.25
P/E
-20.95
EV/Sales
4.91
Sector
Health Care Technology
Category
growth
QHSLab ($USAQ) Review
USAQ (overview): Digital health co w/ 302% YTD return. Q3 rev +62% YoY, margins +10% to 67%, op income +$125k. Oct rev +110% YoY. Debt challenges: 0.17x current ratio, $2.1M liabilities. 53% insider ownership. 2025 proj: $3.15M rev, $412k net income. Risks: weak balance sheet, dilution potential.
Read full article (6 min)